Schipmann Fabian, Bannehr Marwin, Hähnel Valentin, Dworok Victoria, Nübel Jonathan, Edlinger Christoph, Lichtenauer Michael, Haase Michael, Zänker Michael, Butter Christian, Haase-Fielitz Anja
Department of Cardiology, Heart Center Brandenburg Bernau & Faculty of Health Sciences (FGW) Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Ladeburger Straße 17, 16321 Bernau bei Berlin, Germany.
Clinic of Internal Medicine II, Department of Cardiology, Paracelsus Medical University of Salzburg, 5020 Salzburg, Austria.
Diseases. 2022 Mar 16;10(1):16. doi: 10.3390/diseases10010016.
Aim: The impact of chronic kidney disease (CKD) on patient-related outcomes in patients with tricuspid regurgitation (TR) is well known. However, the impact of the progression of CKD in patients with TR and potentially modifiable risk factors of progressing CKD is unknown. Methods: 444 consecutive adult patients with TR and CKD stage 1−4 admitted in an inpatient setting between January 2010 and December 2017 were included. During a median follow-up of two years, eGFR and survival status were collected. Independent risk factors for CKD progression and all-cause mortality were determined. Patient survival statuses were grouped according to different combinations of the presence or absence of CKD progression and the TR grade. Results: Progression of CKD (OR 2.38 (95% confidence interval 1.30−4.35), p = 0.005), the grade of TR (OR 2.38 (1.41−4.00), p = 0.001) and mitral regurgitation (OR 1.72 (1.20−2.46), p = 0.003) were independent risk factors for all-cause mortality. Haemoglobin at admission (OR 0.80 (0.65−0.99), p = 0.043) and the presence of type 2 diabetes (OR 1.67 (1.02−2.73), p = 0.042) were independent risk factors for CKD progression. The combination of the status of CKD progression and the TR grade showed a stepwise pattern for all-cause mortality (p < 0.001). Patients with CKD progression and TR grade 1 had comparable all-cause mortality with patients without CKD progression but with TR grade 2 or 3. Even in patients with TR grade 1, the risk for all-cause mortality doubled if CKD progression occurred (OR 2.49 (95% CI 1.38−4.47), p = 0.002). Conclusion: CKD progression appears to be a risk factor for all-cause mortality in patients with TR. Anaemia and diabetes are potential modifiers of CKD progression.
慢性肾脏病(CKD)对三尖瓣反流(TR)患者的相关预后影响已为人熟知。然而,CKD进展对TR患者的影响以及CKD进展的潜在可改变危险因素尚不清楚。方法:纳入2010年1月至2017年12月期间住院的444例连续成年TR和CKD 1 - 4期患者。在两年的中位随访期间,收集估算肾小球滤过率(eGFR)和生存状态。确定CKD进展和全因死亡率的独立危险因素。根据CKD进展情况和TR分级的不同组合对患者生存状态进行分组。结果:CKD进展(比值比[OR] 2.38[95%置信区间1.30 - 4.35],p = 0.005)、TR分级(OR 2.38[1.41 - 4.00],p = 0.001)和二尖瓣反流(OR 1.72[1.20 - 2.46],p = 0.003)是全因死亡率的独立危险因素。入院时血红蛋白水平(OR 0.80[0.65 - 0.99],p = 0.043)和2型糖尿病的存在(OR 1.67[1.02 - 2.73],p = 0.042)是CKD进展的独立危险因素。CKD进展状态和TR分级的组合对全因死亡率呈逐步变化模式(p < 0.001)。CKD进展且TR 1级的患者与无CKD进展但TR 2级或3级的患者全因死亡率相当。即使在TR 1级的患者中,如果发生CKD进展,全因死亡风险也会加倍(OR 2.49[95%可信区间1.38 - 4.47],p = 0.002)。结论:CKD进展似乎是TR患者全因死亡的危险因素。贫血和糖尿病是CKD进展的潜在影响因素。